 Maria Tucker
Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Freeze Drying | 1 | 2024 | 81 | 0.400 |
Why?
| | Plasma | 1 | 2024 | 220 | 0.360 |
Why?
| | Hemorrhage | 1 | 2024 | 807 | 0.280 |
Why?
| | Solute Carrier Proteins | 1 | 2025 | 1 | 0.230 |
Why?
| | Wounds and Injuries | 1 | 2024 | 944 | 0.230 |
Why?
| | Membrane Transport Proteins | 1 | 2025 | 153 | 0.200 |
Why?
| | Receptors, Pattern Recognition | 1 | 2018 | 12 | 0.140 |
Why?
| | Cryptococcus neoformans | 1 | 2018 | 21 | 0.140 |
Why?
| | Cell Wall | 1 | 2018 | 59 | 0.140 |
Why?
| | Cryptococcosis | 1 | 2018 | 31 | 0.130 |
Why?
| | Immune Evasion | 1 | 2018 | 62 | 0.130 |
Why?
| | Fungal Proteins | 1 | 2018 | 145 | 0.130 |
Why?
| | Host-Pathogen Interactions | 1 | 2018 | 369 | 0.110 |
Why?
| | Blood Component Transfusion | 1 | 2024 | 101 | 0.100 |
Why?
| | South Africa | 1 | 2024 | 265 | 0.100 |
Why?
| | Resuscitation | 1 | 2024 | 304 | 0.080 |
Why?
| | Dinoprostone | 2 | 1989 | 178 | 0.060 |
Why?
| | Knowledge Bases | 1 | 2025 | 28 | 0.060 |
Why?
| | Molecular Sequence Annotation | 1 | 2025 | 104 | 0.050 |
Why?
| | Databases, Protein | 1 | 2025 | 89 | 0.050 |
Why?
| | Data Mining | 1 | 2025 | 115 | 0.050 |
Why?
| | Prodrugs | 1 | 1993 | 52 | 0.050 |
Why?
| | Antibiotics, Antineoplastic | 1 | 1993 | 139 | 0.050 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5862 | 0.050 |
Why?
| | Prospective Studies | 1 | 2024 | 7972 | 0.040 |
Why?
| | Computational Biology | 1 | 2025 | 679 | 0.040 |
Why?
| | Bile | 1 | 1989 | 26 | 0.040 |
Why?
| | Skin Absorption | 1 | 1989 | 13 | 0.040 |
Why?
| | beta-Glucans | 1 | 2018 | 16 | 0.030 |
Why?
| | Methotrexate | 1 | 1989 | 231 | 0.030 |
Why?
| | Protein Transport | 1 | 2018 | 436 | 0.030 |
Why?
| | Prostaglandins E, Synthetic | 1 | 1985 | 2 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1246 | 0.030 |
Why?
| | Antihypertensive Agents | 1 | 1989 | 512 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2018 | 496 | 0.030 |
Why?
| | Skin | 1 | 1989 | 751 | 0.030 |
Why?
| | Middle Aged | 1 | 2024 | 35892 | 0.020 |
Why?
| | Male | 3 | 2024 | 72263 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2018 | 4102 | 0.020 |
Why?
| | Humans | 4 | 2025 | 144298 | 0.020 |
Why?
| | Adult | 1 | 2024 | 40408 | 0.020 |
Why?
| | Macrophages | 1 | 2018 | 1496 | 0.020 |
Why?
| | Female | 2 | 2024 | 78137 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 5954 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1989 | 578 | 0.020 |
Why?
| | Mice | 2 | 2018 | 18218 | 0.010 |
Why?
| | Animals | 4 | 2018 | 37800 | 0.010 |
Why?
| | Leukemia P388 | 1 | 1993 | 7 | 0.010 |
Why?
| | Anthracenes | 1 | 1993 | 31 | 0.010 |
Why?
| | Melanoma, Experimental | 1 | 1993 | 109 | 0.010 |
Why?
| | Rats | 2 | 1993 | 5553 | 0.010 |
Why?
| | Blood Pressure | 2 | 1989 | 1763 | 0.010 |
Why?
| | Pharmaceutical Vehicles | 1 | 1989 | 12 | 0.010 |
Why?
| | Rats, Inbred SHR | 1 | 1989 | 36 | 0.010 |
Why?
| | Autoradiography | 1 | 1989 | 65 | 0.010 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1989 | 84 | 0.010 |
Why?
| | Biotransformation | 1 | 1989 | 63 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1989 | 320 | 0.010 |
Why?
| | Administration, Topical | 1 | 1989 | 152 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1993 | 2512 | 0.010 |
Why?
| | Dogs | 1 | 1985 | 435 | 0.010 |
Why?
| | Kinetics | 1 | 1985 | 1603 | 0.010 |
Why?
|
|
Tucker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|